[ALNY] YoY Quarter Result on 30-Sep-2017 [#Q3]

Stock
[ALNY] Alnylam Pharmaceuticals, Inc.
Announcement Date
07-Nov-2017
Financial Year
2017
Quarter
30-Sep-2017 [#Q3]
Profit Trend
QoQ- -3.81%
YoY- -18.13%
Quarter Report
ALNY's Result
ALNY's Financial Summary
View:
Show?
Quarter Result
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
Revenue 125,853 70,061 2,069 17,096 13,651 6,324 10,972 50.11%
PBT -252,452 -208,929 -244,837 -122,937 -104,071 -76,792 -43,922 33.80%
Tax 839 -394 445 -3,296 -2,204 -1,610 67 52.32%
NP -253,291 -208,535 -245,282 -122,937 -104,071 -76,792 -43,989 33.84%
Tax Rate - - - - - - - -
Total Cost 379,144 278,596 247,351 140,033 117,722 83,116 54,961 37.93%
Ratio Analysis
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
NP Margin -201.26 -297.65 -11,855.10 -719.10 -762.37 -1,214.29 -400.92 -10.84%
Per Share
30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 CAGR
EPS -2.18 -1.92 -2.43 -1.34 -1.21 -0.91 -0.58 24.66%
EPS Diluted -2.18 -1.92 -2.43 -1.34 -1.21 -0.91 -0.58 24.66%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.